To meet the need of the ever-growing demand of increased oral bioavailability of Biopharmaceutics Classification System (BCS) class II active pharmaceutical ingredients (APIs), many formulators are turning to amorphous spray dried dispersions, given their track record of successful bioavailability enhancement. However, some molecules exhibit a high propensity to phase separate and recrystallize from the amorphous…